Perceptive Advisors

Perceptive Advisors

$20,000,000 Venture capital (Series A)
MedCity News

Startup A-Alpha Bio sets out to solve a major protein problem facing big pharma

MedCity News

Invitae to buy health records startup Ciitizen for $325M 

Acquisition
MedCity News

With $60M in new funding, Genome Medical buys genetic counseling company

Pulse 2.0

Report: Exact Sciences (EXAS) Approached Invitae (NVTA) For Merger Offer

Forbes Tech

As Biology Manufacturing Company Zymergen Implodes, Correspondence With SEC Showed Early Doubts

GeekWire

Biotech firm Athira Pharma hit by class action lawsuits following image manipulation claims

GeekWire

Athira Pharma CEO Leen Kawas placed on leave, shares sink more than 30%

GeekWire

Sujal Patel-led Nautilus Biotechnology goes public as it tackles ambitious plan to analyze proteins

CNBC , GeekWire

Biogen shares surge 38% after FDA approves Alzheimer's drug, the first new therapy for the disease in nearly two decades

Forbes Tech

In An Earth Day Test For Synthetic Biology Field, Zymergen Raises $500 Million In IPO

neurons.AI

Relay Therapeutics Snaps up ZebiAI with $85 Million Upfront Payment

Pulse 2.0

Invitae Stock Price: $48 Target By Oppenheimer

Pulse 2.0

Invitae Stock Price Increased Over 10% Pre-Market: Why It Happened

Pulse 2.0

Cidara Therapeutics Stock Price Increased Over 5% Pre-Market: Why It Happened

$168,000,000 Venture capital (Series D)
WSJ Venture Capital

Crossover Health Raises $168 Million to Grow Primary-Health Services

GeekWire

Jeff Bezos-backed startup Nautilus Biotechnology set to go public via SPAC at $900M valuation

$55,000,000 Venture capital (Series C)
FinSMEs

Willow Raises $55M in Series C Funding

GeekWire

Athira Pharma raises $204M in IPO, reaching ‘big milestone’ in fight against Alzheimer’s and other diseases

GeekWire

Athira Pharma prices IPO at $17/share, will raise $204M in third Washington state IPO of 2020

GeekWire

Seattle biotech Athira Pharma sets terms for IPO, aims to raise up to $170M